For researchers

If you have an early or complex late-phase study, commercial or otherwise, our facility is here for your use.

Guidance on using the facility can be downloaded here. We work closely with the University Hospital Southampton R&D department to manage studies effectively.

As soon as possible you should:

  • talk to us about facility capabilities, requirements and costs
  • If you are conducting a Phase I study, you will also need to complete an Early Phase Safety Committee Risk Assessment Form, to get the latest version of this form, please contact Chris Blackwell, christopher.blackwell@uhs.nhs.uk, 023 8120 8819

Our key contacts for advice and queries

Approval process

The registration form is used by our management team to rapidly evaluate the appropriateness, resources and funding of each study requesting use of the facility.

The principal investigator (PI) will receive a formal letter from the facility director, stating whether the registration has been accepted, deferred or rejected.

After acceptance, your study will be allocated a dedicated research nurse who will work with you to initiate the project and, after full approval is given by UHS R&D, support you in achieving rapid and full recruitment.

Further information and resources for undertaking research within the Trust can be found here.

In-trial support

We’re here to support you as efficiently and helpfully as possible; please see our contact page for key contacts.

The clinical research facility user guidelines provide information about the facilities and equipment that are available within the unit and our working procedures.

Please remember that the facility has a duty to report to its funders the outputs of research conducted in the unit. All researchers must acknowledge the NIHR Southampton Clinical Research Facility in any publication or external output, and inform us of any relevant publications or conference presentations generated by clinical research activity within the facility (see the joint university-trust publication policy here).